RNA Interference Functions as an Antiviral Immunity Mechanism in Mammals
Diverse eukaryotic hosts produce virus-derived small interfering RNAs (siRNAs) to direct antiviral immunity by RNA interference (RNAi). However, it remains unknown whether the mammalian RNAi pathway has a natural antiviral function. Here, we show that infection of hamster cells and suckling mice by Nodamura virus (NoV), a mosquito-transmissible RNA virus, requires RNAi suppression by its B2 protein. Loss of B2 expression or its suppressor activity leads to abundant production of viral siRNAs and rapid clearance of the mutant viruses in mice. However, viral small RNAs detected during virulent infection by NoV do not have the properties of canonical siRNAs. These findings have parallels with the induction and suppression of antiviral RNAi by the related Flock house virus in fruit flies and nematodes and reveal a mammalian antiviral immunity mechanism mediated by RNAi.
R NA interference (RNAi) acts as a natural antiviral defense in plants, insects, nematodes, and fungi; accordingly, virulent infection in these organisms requires suppression of antiviral RNAi by a virus-encoded suppressor of RNAi (VSR) (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) . Induction of antiviral RNAi depends on the processing of virus-specific double-stranded RNA (dsRNA) by Dicer nuclease into 21-to 24-nucleotide (nt) small interfering RNAs (siRNAs), which are short dsRNAs with two unpaired nucleotides at the 3 end of either strand (1) (2) (3) (4) (5) (6) (7) (8) (9) . Mammalian viral mRNAs are as susceptible as cellular mRNAs to RNAi programmed by synthetic siRNAs, and virus-derived small RNAs (vsRNAs) are found in mammalian cells infected by RNA viruses (9, 13, 14) . Mammalian viral proteins that can suppress insect and plant RNAi or artificially induced RNAi in mammalian cells have been identified, and the virulence function of one such protein can be complemented by distinct siRNAsequestering plant VSRs (9, (15) (16) (17) (18) (19) . However, it remains unknown whether virus infection triggers production of canonical viral siRNAs in mammals or if mammalian virus infections require specific suppression of an antiviral RNAi response (9) .
Nodamura virus (NoV) is mosquito-transmissible, highly virulent to suckling mice and suckling hamsters, and belongs to the same bipartite positivestrand RNA virus genus as Flock house virus (FHV), an insect pathogen (20) . FHV infection in Drosophila requires expression of its VSR protein B2, a dsRNA-binding protein, to inhibit Dicer processing of dsRNA viral replication intermediates into siRNAs (3, 12, (21) (22) (23) (24) . Clearance of a B2-deficient FHV mutant in cultured Drosophila cells is therefore associated with abundant accumulation of viral siRNAs (24) . Because the B2 ortholog of NoV exhibits similar in vitro VSR activities and suppresses experimental RNAi in mammalian cells (15, 16, 24) , we reasoned that use of NoVDB2, a B2-deficient mutant of NoV (25) , to challenge baby hamster kidney 21 (BHK-21) cells might facilitate detection of mammalian viral siRNAs. In two independent experiments, we compared deep sequencing profiles of 18-to 28-nt small RNAs from BHK-21 cells 2 or 3 days postinoculation (dpi) with either NoVor NoVDB2. In cells infected by NoV, vsRNAs were highly abundant, but they displayed an overwhelming bias for positive strands (~97%), showed no size preference expected for Dicer products www.sciencemag.org SCIENCE VOL 342 11 OCTOBER 2013 (Fig. 1A and table S1), and are likely breakdown products from the abundant positive-strand viral RNAs (9) .
By contrast, vsRNAs from NoVDB2-infected cells were much less abundant and exhibited reduced positive-strand bias (~85%) (table S1). Notably,~77% of the total negative-strand vsRNA reads in both libraries were in the 21-to 23-nt size range with a major 22-nt peak, similar to Dicerdependent cellular microRNAs (Fig. 1A and fig.  S1A ). The unique negative-strand vsRNAs also had a dominant 22-nt peak ( fig. S1B ). Therefore, NoVDB2 vsRNAs display patterns of length distribution and strand bias expected for Dicer products as found for plant and invertebrate viral siRNAs (9) .
NoV B2 vsRNAs exhibited properties of canonical siRNAs (Fig. 1B and table S1 ). First, both NoV B2 libraries were enriched for a population of 22-nt vsRNAs that contained a 20-nt perfectly base-paired duplex region with 2-nt 3 overhangs (Fig. 1B , peak "-2" and siRNAs a/b). Enrichment for 22-nt canonical siRNA pairs was not found for the comparably much more abundant vsRNAs of NoV (Fig. 1B) . Second, we detected a more dominant population of complementary 22-nt vsRNA pairs with 20-nt 5-end overhangs only for NoV B2 vsRNAs (Fig. 1B , peak "20" and siRNAs a/g). These findings together suggest Dicer-dependent processing of the same viral dsRNA precursor into successive 22-nt viral siRNA duplexes in cells infected by NoV B2, but not by NoV.
In contrast to the efficient infection of BHK-21 cells by B2-expressing NoV (25) , NoV B2 maintained infection only at low levels (Fig. 2) . Higher accumulation levels of NoV B2 were restored ( Fig. 2) , however, in BHK-21 cells engineered with a stably expressed transgene encoding either NoV B2 or Ebola virus virion protein 35 (VP35), the latter of which suppresses experimental RNAi in mammalian cells by a distinct mechanism (26, 27) . These results show that RNAi suppression by a cognate or heterologous VSR expressed from either the viral genome or an ectopic transgene is essential for robust virus infection in mammalian cells. We conclude therefore that NoV B2 is defective only in RNAi suppression, and the RNAi response induced by NoV B2, characterized by the production of viral siRNAs, has potent antiviral activity in BHK-21 cells. Consistently, rescue of NoV B2 infection was also observed in RNAi-defective mouse embryonic stem cells deleted of all Argonaute genes (28) .
NoV is lethal to 7-day-old mice when injected intraperitoneally (29) . Quantitative reverse transcription polymerase chain reaction (RT-PCR) analysis validated the spread of both NoV and NoV B2 from the injected abdominal cavity to the fore-and hindlimb tissues 24 hours after inoculation (Fig. 3A) . The difference between NoV and NoV B2 accumulation levels was small at 1 dpi, although higher doses of NoV B2 were inoculated into each mouse (supplementary materials), but became progressively more pronounced at later infection times. By 4 dpi, NoV RNA levels were comparable to those of ribosomal RNAs (rRNAs), whereas the accumulation of NoV was more than 1000 times that of NoV B2 (Fig. 3, A  and B) . Accordingly, unlike the 100% mortality observed 5 days post-NoV infection, suckling mice challenged by NoV B2 remained healthy for the duration of the experiment, up to 4 weeks postinoculation (Fig. 3C) . Our quantitative RT-PCR analysis on the expression of 84 key genes from the known innate antiviral pathways (30) in suckling mice at 4 dpi detected no major differences between infection by NoV B2 and NoV (table S2) . This suggested that rapid in vivo clearance of NoV B2 was not mediated by one of the known innate antiviral pathways. Moreover, we found that a NoV mutant (NoVmB2) carrying a single Arg to Gln mutation at position 59 of B2, known to abolish B2's VSR activity in vitro (3, 24) , was as nonvirulent as NoV B2 in suckling mice and was also progressively cleared from 4 dpi (Fig. 3A) . Thus, in vivo infection and virulence of NoV require the RNAi suppressor activity of B2.
Northern blot hybridization detected accumulation of discrete species of viral siRNAs in NoVDB2-inoculated suckling mice (Fig. 3D , right panel), as found in plant and invertebrate hosts after virus infection (1, 2, 9 ). The mouse viral siRNAs migrated as a dominant 22-nt band alongside a weaker, 21-nt signal and became detectable at 2 dpi and remained so up to 7 dpi even through the accumulation of NoV B2 was low at both 2 and 7 dpi (Fig. 3, A and B) . In contrast, vsRNAs from NoV-infected mice appeared as bands of heterogeneous sizes (Fig. 3D,  right panel) . Notably, the 22-nt viral siRNAs became readily detectable in suckling mice inoculated with NoVmB2 (Fig. 3D, left panel) . Therefore, rapid virus clearance resulting from loss of viral suppression of RNAi in NoV B2-and NoVmB2-infected mice was consistently accompanied with abundant production of the 22-nt viral siRNAs.
We further deep sequenced small RNAs from suckling mice 4 days after NoV inoculation and from those 1 or 2 days after NoV B2 inoculation. NoV vsRNAs showed no size preference, and the 22-nt vsRNAs of NoV were not enriched for canonical siRNAs (Fig. 4, A and B) , which suggested B2 suppression of viral siRNA biogenesis in NoV-infected mice. We noted that NoV vsRNAs cloned from mice contained more abundant negative strands (16%) than those from cell culture (3%) (table S1), which might indicate weak in vivo dicing of NoV dsRNA in the presence of B2. In contrast,~85% of NoV B2 small RNAs from mice were 21-to 23-nt long, with 22 nt as the predominant size for both strands (Fig. 4A  and fig. S1B ). A higher density of viral siRNAs was found to target the RNA3-transcribing region of RNA1 and the 5-terminal region of RNAs 1 and 2 in NoV B2-infected mice and BHK-21 cells (Fig. 4C) . The relative abundance of viral siRNAs in NoV B2-infected mice (0.3%) (table S1) was similar to that found in fruit flies (0.5 to 0.9%) undergoing FHV B2 clearance (12) . NoV B2 siRNAs from mice at 2 dpi were divided approximately equally into positive and negative strands (Fig. 4A), (Fig. 4B and table S1 ). The 22-nt viral siRNAs of NoV B2 detected by Northern blotting therefore have the properties of canonical viral siRNAs processed from dsRNA viral replication intermediates, which demonstrates induction of a typical antiviral RNAi response in mice by NoV B2 infection. Together, our findings reveal that, without viral suppression of RNAi, mice are able to launch a potent antiviral RNAi response sufficiently effective to provide full protection from lethal viral infection.
Here, we have found that an RNA virus infection in cultured hamster cells and suckling mice induces a typical antiviral RNAi response, characterized by the production of viral siRNAs with clearly defined properties of canonical siRNAs. Our findings and those of Maillard et al. (28) illustrate that Dicer-dependent processing of dsRNA viral replication intermediates into successive siRNAs is a conserved mammalian immune response to infection by two distinct positivestrand RNA viruses (table S3) . Consistent with the known in vitro activity of the B2 protein to inhibit the processing of long dsRNA into siRNAs (3, 16, 21, 24) , however, viral small RNAs detected by either deep sequencing or Northern blotting during wild-type NoV infection do not have the properties of canonical siRNAs. Northern blot detection of viral siRNAs in NoV B2-infected mice suggests that the use of in vivo infection models and/or viruses incapable of inhibiting siRNA biogenesis may facilitate detection of siRNAs targeting other mammalian viruses. Moreover, NoV infection both in vitro and in vivo requires the RNAi suppressor activity of its B2 protein. In particular, suckling mice produced abundant viral siRNAs and became completely resistant to the lethal infection by NoV after substitution of a single amino acid in B2 that eliminates its RNAi suppressor activity. Thus, the typical RNAi response induced by virus infection in mammals has potent antiviral activity. The striking similarities in the induction and suppression of antiviral RNAi by the closely related FHVand NoV in fruit flies, nematodes, and mammals (2, 3, 8, 12, (21) (22) (23) (24) highlight an evolutionary conserved role of RNAi in antiviral defense within the animal kingdom. Compared with the antiviral immunity mechanisms reported to date in mammals, virus clearance by antiviral RNAi has a distinct effector mechanism and does not require cell death (9, 30) . Nevertheless, this mammalian immunity mechanism exhibits properties known to be associated with innate and adaptive immunity because it involves rapid host recognition of a microbeassociated molecular pattern dsRNA and a mechanism of specificity determined by pathogen-derived siRNAs (9) . Discovery of mammalian antiviral RNAi provides a framework to investigate the innate and adaptive control of important human viral pathogens.
